Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “mRNA: Therapeutics and Global Markets” is forecast to remain stable or slightly decline to $7.69 billion...
 - 
                            
BANDUNG, Indonesia, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers’ Network...
 - 
                            
Amidst government conflict and chaos this week, President Trump achieved another major historic step toward world global PEACE.
 - 
                            
The new Trusted Teen CommUNITY program will empower and mobilize teens to serve as trusted health ambassadors for vaccination and preventive health.
 - 
                            
Phase 2b to assess efficacy, safety, and immunogenicity2,850 participants to be enrolled across European countries Lyon, France and Liège, Belgium – September 16, 2025 – Osivax, a biopharmaceutical...
 - 
                            
Washington, DC, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/09/12/week-34-of-the-trump-administration/ ThinkCareBelieve has...
 - 
                            
Washington, DC, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/08/30/week-32-of-america-and-trump-2-0/ There has not been one dull...
 - 
                            
Hannaford is now offering flu shots at its in-store pharmacies in Maine, New Hampshire, New York, Massachusetts and Vermont.
 - 
                            
Funding to accelerate development of Osivax’ broad-spectrum influenza A vaccine candidate, OVX836 Lyon, France and Liège, Belgium – August 26, 2025 – Osivax, a biopharmaceutical company developing...
 - 
                            
BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...